HIVandHepatitis.com
 Google Custom Search
Zerit (d4T, stavudine)

Articles on Zerit
Full US Prescribing Information

Zerit is in a category of HIV medications called nucleoside reverse transcriptase inhibitors (NRTIs).

Zerit, manufactured by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration for the treatment of HIV in 1994.


Articles on Zerit


Benefits versus Risks of Stavudine (Zerit) Therapy for HIV-related Neurological Complications - 2/03/09

Longer Exposure to NRTIs, especially Stavudine (Zerit), Increases the Risk of Insulin Resistance in Women with HIV - 1/30/09


What Is the Impact on Lipoatrophy and Dyslipidemia of Reducing the Dose of d4T (Zerit) Compared with Switching to Tenofovir (Viread)?
- 1/15/08